Detection of lupus anticoagulant identifies patients with autoimmune haemolytic anaemia at increased risk for venous thromboembolism

British Journal of Haematology

Volumn 118, Issue 4, 2002, Pages 1166-1169

  Pullarkat, Vinod ^a   Ngo, Mark ^a   Iqbal, Syma ^a   Espina, Byron ^a   Liebman, Howard A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Autoimmune; Haemolytic anaemia; Lupus anticoagulant; Thrombosis

Indexed keywords

CARDIOLIPIN; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; LUPUS ANTICOAGULANT ANTIBODY; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ANTICOAGULATION; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK POPULATION; HUMAN; MALE; MORBIDITY; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; THROMBOEMBOLISM;

EID: 0036042531     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03729.x     Document Type: Article

References (23)

1. Idiopathic acquired autoimmune hemolytic anemia. A review of forty seven cases treated from 1955 through 1965
2. Thromboembolic events in beta thalassemia major: An Italian multicenter study
3. Criteria for the diagnosis of lupus anticoagulants: An update
4. Biologic false-positive tests for syphilis and other serologic abnormalities in autoimmune hemolytic anemia and thrombocytopenic purpura
5. Autoimmune hemolytic anemia. Analysis of hematologic observations with particular reference to their prognostic value. A survey of 57 cases
6. The autoimmune hemolytic anemias
7. The serology and the prognosis of 128 cases of autoimmune hemolytic anemia
8. Abnormalities of membrane protein composition in patients with autoimmune haemolytic anaemia
9. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns
10. Hemostatic system activation in patients with lupus anticoagulant and essential thrombocytopenia
11. Inhibitors of blood coagulation
12. Lupus anticoagulant and increased thrombin generation in patients with systemic lupus erythematosus
13. Antiphospholipid antibodies in patients with idiopathic hemolytic anemia
14. Hereditary spherocytosis, thrombosis and chronic pulmonary emboli: A case report and review of the literature
15. Antiphospholipid antibodies in systemic lupus erythematosus: Evidence of an association with positive Coombs' and hypocomplementemia
16. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus: Comparison between different assays for the detection of antiphospholipid antibodies
17. Autoimmune hemolytic anemia in patients with systemic lupus erythematosus
18. Erythrocyte membrane proteins reactive with human (warm-reacting) anti-red cell autoantibodies
19. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders
20. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin
21. Mechanism and effects of lupus anticoagulant IgG and prothrombin to surface phospholipids
22. Erythroid phosphatidyl serine exposure is not predictive of thrombotic risk in mice with hemolytic anemia
23. Clinical and laboratory observations on autoimmune hemolytic disease